Compare ENGN & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENGN | GENC |
|---|---|---|
| Founded | 1999 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Construction/Ag Equipment/Trucks |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.3M | 205.4M |
| IPO Year | N/A | N/A |
| Metric | ENGN | GENC |
|---|---|---|
| Price | $8.57 | $12.65 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $22.71 | N/A |
| AVG Volume (30 Days) | ★ 314.7K | 27.7K |
| Earning Date | 12-19-2025 | 12-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.92 |
| EPS | N/A | ★ 1.07 |
| Revenue | N/A | ★ $115,437,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.91 |
| Revenue Growth | N/A | ★ 2.01 |
| 52 Week Low | $2.65 | $10.80 |
| 52 Week High | $11.14 | $19.91 |
| Indicator | ENGN | GENC |
|---|---|---|
| Relative Strength Index (RSI) | 56.36 | 43.59 |
| Support Level | $7.57 | $12.86 |
| Resistance Level | $8.47 | $13.68 |
| Average True Range (ATR) | 0.64 | 0.59 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 63.69 | 22.44 |
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.